CannLabs Inc. (OTC: CANL), a provider of proprietary cloud-based analytics and scientific testing methodologies relating to cannabis, recently announced the launch of StrainData™ at www.straindata.com. Using patent-pending technology, the app features proprietary cannabinoid profiles designed to help consumers make informed decision when selecting cannabis and related products in Colorado dispensaries.

“Powered by CannLabs’ analytics, it combines the most trusted testing data in the industry with leading scientific research on how various cannabinoids affect the body,” said Mark Mirken, Chief Executive Officer of CannLabs, Inc. “The ability for StrainData to scale into other legalized cannabis markets will drive additional revenue opportunities … It creates a platform from which dispensaries and growers will realize greater exposure.”

The web app lets individuals select either medical or adult-use marijuana, and if applicable, the ailments that they are hoping to address with the medicine. After making the selections, the app provides a list of cannabis products meeting those criteria. Users can select the products they’re interested in to learn more about their chemical make-up, where they can be found in various dispensaries on a map, and related products to consider.

The data that appears in the app comes from CannLabs’ own laboratories, which means there’s a high level of data integrity. For consumers, this means that they can trust the information that they find on the web app. For businesses, the web app provides a unique platform to reach serious consumers and creates an added benefit of using CannLabs’ laboratories over other providers in the state given the increased exposure.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.